Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03966352 · ClinicalTrials.gov registry record
Pathways to Fatherhood
A clinical trial, sponsored by Reproductive Medicine Associates of New Jersey.
- Completed
- Registry status
- 21
- Enrollment target
NCT03966352: Completed study, sponsored by Reproductive Medicine Associates of New Jersey.
NCT03966352 is a clinical trial that has completed, run by Reproductive Medicine Associates of New Jersey. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03966352 has completed, sponsored by Reproductive Medicine Associates of New Jersey.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the decision-making process that gay couples go through in order to have children.
Primary Outcome
assess response to questions regarding quality of life, general health, demographic info as well as vies on sperm, egg donation, gestational carriers, legal and financial issues as well as adoption or foster care
Interventions
- OTHER Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-05-24 |
| Est. Completion | 2019-12-31 |
What the finished NCT03966352 record still lists
NCT03966352 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT03966352 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03966352 about?
NCT03966352 is a clinical study titled "Pathways to Fatherhood". The purpose of this study is to better understand the decision-making process that gay couples go through in order to have children.
What is the current status of trial NCT03966352?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2019-05-24. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03966352?
The interventions under investigation include: Questionnaire (OTHER).
Who is sponsoring clinical trial NCT03966352?
This trial is sponsored by Reproductive Medicine Associates of New Jersey, which has 51 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI